Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > DPPIV

DPPIV

Brief Information

Name:Dipeptidyl peptidase IV
Target Synonym:Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
Number of Launched Drugs:34
Number of Drugs in Clinical Trials:31
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

DP4-C52H9-SPR
Human_FcRn_Heterodimer_Protein_SPR

MERS S1 protein, His Tag (Cat. No. S1N-M52H5) immobilized on CM5 Chip can bind Cynomolgus DPPIV, His Tag (Cat. No. DP4-C52H9) with an affinity constant of 60.7 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

DP4-H5221-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human DPPIV, His Tag (Cat. No. DP4-H5221) immobilized on CM5 Chip can bind MERS S1 protein, His Tag (Cat. No. S1N-M52H5) with an affinity constant of 0.303 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Synonym Name

DPP4,ADABP,ADCP2,CD26,DPPIV,TP103

Background

Dipeptidyl peptidase-IV (DPPIV) is also known as adenosine deaminase complexing protein 2, DPPIV or CD26 is antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPPIV are proline (or alanine)-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others. DPPIV also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Anagliptin SK-0403; CWP-0403 Approved Sanwa Kagaku Kenkyusho Co Ltd Suiny, Beskoa Japan Diabetes Mellitus, Type 2 null 2012-09-28 Diabetes Mellitus, Type 2 Details
Teneligliptin Hydrobromide Hydrate/Canagliflozin Hemihydrate Approved Mitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co Ltd Canalia Japan Diabetes Mellitus, Type 2 Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma 2017-07-03 Diabetes Mellitus, Type 2 Details
Vildagliptin/Metformin Hydrochloride LMF-237 Approved Novartis Pharma Ag 宜合瑞, Eucreas, EquMet, Zomarist, Icandra EU Diabetes Mellitus, Type 2 Novartis Europharm Ltd 2007-11-14 Diabetes Mellitus, Type 2 Details
Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate Approved Lg Life Sciences Ltd ZemiStatin Diabetes Mellitus, Type 2; Dyslipidemias Details
Linagliptin/Empagliflozin BI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356 Approved C.H. Boehringer Sohn Ag & Co. Kg Tradiance, Glyxambi, Esgliteo United States Diabetes Mellitus, Type 2 Boehringer Ingelheim Gmbh 2015-01-30 Diabetes Mellitus, Type 2; Cardiovascular Diseases Details
Linagliptin BI-1356; BI-1356-BS Approved Boehringer Ingelheim Gmbh 欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, Tradjenta United States Diabetes Mellitus, Type 2 Boehringer Ingelheim Gmbh 2011-05-02 Prediabetic State; Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Schizophrenia; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Hypertension; Endocrine System Diseases; Coronavirus Infections; Metabolic Diseases; Hepatic Insufficiency; Glucose Metabolism Disorders; Inflammation; Diabetes Mellitus; Ventricular Dysfunction, Left Details
Sitagliptin Tartrate Approved Heumann Pharma GmbH & Co Generica KG Sitagliptin Heumann 25 mg Filmtabletten EU Heumann Pharma GmbH & Co Generica KG 2020-12-14 Diabetes Mellitus, Type 1; Parkinson Disease; Diabetic Nephropathies Details
Metformin Hydrochloride/Sitagliptin Hydrochloride Approved Sandoz Bv EU Sandoz Bv 2019-12-10 Diabetes Mellitus, Type 2 Details
Evogliptin DA-1229 Approved Dong-A Pharmaceutical Co Ltd Suganon, Sugarnon South Korea Diabetes Mellitus, Type 2 Dong-A Pharmaceutical Co Ltd 2015-10-02 Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases Details
Alogliptin Benzoate/Metformin Hydrochloride CT-L01; CT-L-01 Approved Takeda Pharmaceutical Co Ltd Vipdomet, Inisync, Kazano United States Diabetes Mellitus, Type 2 Takeda Pharmaceuticals U.S.A. Inc 2013-01-25 Diabetes Mellitus, Type 2 Details
Vildagliptin LAF-237; DSP-7238; LAF-237A; NVP-LAF-237 Approved Novartis Pharma Ag 佳维乐, Equa, Jalra, Galvus, Gliptus, Xiliarx EU Diabetes Mellitus, Type 2 Novartis Europharm Ltd 2007-09-25 Prediabetic State; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Renal Insufficiency; Schizophrenia; Kidney Diseases; Insulin Resistance; Dyslipidemias; Diabetes, Gestational; Diabetes Mellitus Details
Gemigliptin L-tartrate Sesquihydrate LC-150444; LC-15-0444 Approved Lg Life Sciences Ltd Gemiglo, Zemiglo South Korea Diabetes Mellitus, Type 2 Lg Life Sciences Ltd 2012-06-27 Diabetes Mellitus, Type 2; Hepatic Insufficiency Details
Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride Approved Handok Inc Tenelia M SR South Korea Diabetes Mellitus, Type 2 Handok Inc 2015-11-03 Diabetes Mellitus, Type 2 Details
Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride Approved Astrazeneca Plc Qtern EU Diabetes Mellitus, Type 2 Astrazeneca Ab 2016-07-15 Diabetes Mellitus, Type 2 Details
Saxagliptin Hydrochloride/Metformin Hydrochloride Approved Astrazeneca Pharmaceutical Co Ltd 安立格, Kombiglyze Xr, Komboglyze EU Diabetes Mellitus, Type 2 Astrazeneca Ab 2010-11-05 Diabetes Mellitus, Type 2 Details
Evogliptin Tartrate/Metformin Hydrochloride DA-1229_01 Approved Dong-A Pharmaceutical Co Ltd Sugamet XR South Korea Diabetes Mellitus, Type 2 Dong-A Pharmaceutical Co Ltd 2015-12-01 Diabetes Mellitus, Type 2 Details
Linagliptin/Metformin Hydrochloride GC2129A; GC-2129-A; DW6013 Approved Boehringer Ingelheim Gmbh Jentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁 United States Diabetes Mellitus, Type 2 Boehringer Ingelheim Gmbh 2012-01-30 Diabetes Mellitus, Type 2 Details
Empagliflozin/Linagliptin/Metformin Approved Boehringer Ingelheim Gmbh, Eli Lilly And Company Trijardy XR United States Diabetes Mellitus, Type 2 Boehringer Ingelheim Gmbh 2020-01-27 Diabetes Mellitus, Type 2 Details
Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride Approved Lg Life Sciences Ltd ZemiMet SR South Korea Diabetes Mellitus, Type 2 Lg Life Sciences Ltd 2015-01-01 Diabetes Mellitus, Type 2 Details
Sitagliptin Hydrochloride Approved EU Diabetes Mellitus, Type 2 Laboratorios Alter Sa 2018-11-27 Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome Details
Gemigliptin Approved Details
Sitagliptin/Ertugliflozin Approved Pfizer Pharmaceuticals Ltd (China) Steglujan United States Diabetes Mellitus, Type 2 Merck & Co Inc 2017-12-19 Diabetes Mellitus, Type 2 Details
Sitagliptin Phosphate/Metformin Hydrochloride Approved Merck & Co Inc Velmetia, Janumet, 捷诺达, Zituvimet United States Diabetes Mellitus, Type 2 Merck & Co Inc 2007-03-30 Diabetes Mellitus, Type 2 Details
Retagliptin Phosphate SP-2086 Phosphate Approved Jiangsu Hengrui Medicine Co Ltd 瑞泽唐 Mainland China Diabetes Mellitus, Type 2 Jiangsu Hengrui Medicine Co Ltd 2023-06-27 Diabetes Mellitus, Type 2; Renal Insufficiency; Diabetes Mellitus Details
Trelagliptin Succinate TAK-472; SYR-472; SYR-111472; SYR-111472 succinate Approved Takeda Pharmaceutical Co Ltd Zafatek Japan Diabetes Mellitus, Type 2 Takeda 2015-03-26 Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Sitagliptin Phosphate Monohydrate ONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715 Approved Merck Sharp & Dohme Corp Ristaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS X United States Diabetes Mellitus, Type 2 Merck & Co Inc 2006-10-16 Gastroparesis; Carcinoma, Hepatocellular; Hyperlipidemias; Kidney Failure, Chronic; Diabetes Mellitus; Inflammation; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Renal Insufficiency, Chronic; Cardiovascular Diseases; Hepatic Insufficiency; Hepatitis C; Psoriasis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Cystic Fibrosis; Insulin Resistance; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Graft vs Host Disease; Glucose Intolerance; Atherosclerosis; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2; Heart Failure; HIV Infections; Prediabetic State; Diabetes Mellitus, Type 1; Leukemia, Myelogenous, Chronic Details
Saxagliptin Hydrate BMS-477118; BMS-477118-11; OPC-262 Approved Bristol-Myers Squibb Company 安立泽, Onglyza EU Diabetes Mellitus, Type 2 Astrazeneca Ab 2009-07-31 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia; Diabetes Mellitus Details
Alogliptin Benzoate/Pioglitazone Hydrochloride SYR-322-4833 BL Approved Takeda Pharmaceutical Co Ltd Nesinaact, Oseni, Liovel, Incresync Japan Diabetes Mellitus, Type 2 Takeda 2011-07-01 Diabetes Mellitus, Type 2 Details
Teneligliptin Hydrobromide Hydrate MP-513 Approved Mitsubishi Tanabe Pharma Tenelia, Tenglyn Japan Diabetes Mellitus, Type 2 Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd 2012-06-29 Diabetes Mellitus, Type 2 Details
Omarigliptin MK-3102 Approved Merck & Co Inc Marizev Japan Diabetes Mellitus, Type 2 Merck Sharp & Dohme Corp 2015-09-28 Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Diabetes Mellitus Details
Alogliptin Benzoate SYR-322; TAK-322 Approved Takeda Nesina, 尼欣那, Vipidia Japan Diabetes Mellitus, Type 2 Takeda 2010-04-06 Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus Details
Teneligliptin/Pioglitazone Approved Glenmark Pharmaceuticals Ltd Zita Plus Pio India Diabetes Mellitus, Type 2 Glenmark Pharmaceuticals Ltd 2022-04-25 Diabetes Mellitus, Type 2 Details
Anagliptin/Metformin Hydrochloride SK-1501 Approved Sanwa Kagaku Kenkyusho Co Ltd, Suzuken Metoana Japan Diabetes Mellitus, Type 2 Sanwa Kagaku Kenkyusho Co Ltd 2018-09-21 Diabetes Mellitus, Type 2 Details
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline MK-0431J Approved Merck & Co Inc, Astellas Pharma Inc Sujanu Japan Diabetes Mellitus, Type 2 null 2018-03-23 Diabetes Mellitus, Type 2 Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
REC-04 Clinical Recardio Inc Cardiovascular Diseases Details
Yogliptin Phase 3 Clinical Sichuan Sunheal Pharmaceutical Co Ltd, Chengdu Easton Biopharmaceuticals Co Ltd Diabetes Mellitus, Type 2 Details
Bogliptin maleate HL012MA Phase 2 Clinical Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, East China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Retagliptin Phosphate/Metformin Hydrochloride HRX-0701 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Diabetes Mellitus, Type 2 Details
TSL-0319 TSL-0319 Phase 1 Clinical Jiangsu Tasly Diyi Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Talabostat PT-100; BXCL-701 Phase 2 Clinical Midatech Pharma Plc, Bioxcel Therapeutics Inc Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms, Germ Cell and Embryonal; Carcinoma, Small Cell; Lung Neoplasms; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Prostatic Neoplasms; Solid tumours; Neuroblastoma; Sarcoma; Neuroendocrine Tumors; Central Nervous System Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Myelodysplastic Syndromes; Kidney Neoplasms; Liver Neoplasms; Ovarian Neoplasms Details
Dapagliflozin/Sitagliptin SID-1903; DW-6012 Phase 3 Clinical Astrazeneca Sa Diabetes Mellitus, Type 2; ST Elevation Myocardial Infarction; Myocardial Infarction Details
Evogliptin Tartrate LY-05007 Phase 1 Clinical Dong-A Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Linagliptin/Fimasartan Potassium Trihydrate Phase 1 Clinical Boryung Pharmaceutical Co Ltd Hypertension; Diabetes Mellitus Details
YS-110 YSCMA; YS-110 Phase 2 Clinical Y'S Therapeutics Inc Mesothelioma Details
Metformin/Dapagliflozin/Sitagliptin GMRx4 Phase 2 Clinical George Medicines PTY Ltd, George Medicines UK Ltd Diabetes Mellitus, Type 2 Details
Dutogliptin Tartrate/Metformin Hydrochloride Phenomix Corporation Details
TQ-05510 TQ-05510 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd Diabetes Mellitus, Type 2 Details
TOTUM•63 TOTUM-63 Phase 3 Clinical Valbiotis Diabetes Mellitus, Type 2 Details
Lobeglitazone/Sitagliptin CKD-396 Phase 1 Clinical Chong Kun Dang Pharmaceutical Corp Diabetes Mellitus, Type 2 Details
Singletine DC-291407; DC-407; DC291407 Phase 2 Clinical Cisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Diabetes Mellitus, Type 2; Fatty Liver Details
LID104 LID104; LID-104 Phase 3 Clinical Ems Diabetes Mellitus, Type 2 Details
THDBH-100 THDBH100; THDBH101 Phase 1 Clinical Wuxi Apptec(Shanghai) Co Ltd Diabetes Mellitus, Type 2 Details
Dutogliptin Tartrate REC-01; PHX-1149; PHX-1149T Phase 3 Clinical Phenomix ST Elevation Myocardial Infarction; Myocardial Infarction; Diabetes Mellitus, Type 2; Kidney Diseases; Leukemia, Myeloid, Acute Details
WXSHC-071 WXSHC-071 Phase 1 Clinical Dongbao Zixing (Hangzhou) Biological Medicine Co Ltd Diabetes Mellitus, Type 2 Details
Begelomab SAND-26; BT 5/9 Phase 2 Clinical Adienne Dermatomyositis; Graft vs Host Disease Details
TQ-F3083 TQ-F3083; CT-383 Phase 2 Clinical Beijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Diabetes Mellitus, Type 2; Diabetes Mellitus Details
CGT-2201 CGT-2201 Phase 1 Clinical Cgenetech(Suzhou China) Co Ltd Diabetes Mellitus, Type 2; Diabetes Mellitus Details
CPL2009-0031 Phase 3 Clinical Cadila Healthcare Ltd Diabetes Mellitus, Type 2 Details
Augliptin Hydrochloride Phase 1 Clinical Shanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd, Nanjing Changao Pharmaceutical Science And Technologyco Ltd Diabetes Mellitus, Type 2 Details
Sitagliptin/Telmisartan HDDO-16091 + HDDO-16092; HOB-077; HDDO-1609 Phase 1 Clinical Hyundai Pharmaceutical Co Ltd Hypertension; Diabetes Mellitus Details
Empagliflozin/Metformin/Sitagliptin Phase 1 Clinical Taizhou Overseas Pharmaceuticals Co Ltd Diabetes Mellitus, Type 2 Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message